Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.977
-0.003 (-0.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.997
+0.020 (2.06%)
After-hours: Jun 26, 2026, 7:37 PM EDT

Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $3.60 million. The enterprise value is $178,592.

Market Cap 3.60M
Enterprise Value 178,592

Important Dates

The next estimated earnings date is Thursday, August 13, 2026, before market open.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

Onconetix has 3.69 million shares outstanding.

Current Share Class 3.69M
Shares Outstanding 3.69M
Shares Change (YoY) n/a
Shares Change (QoQ) +100.37%
Owned by Insiders (%) 0.01%
Owned by Institutions (%) 0.19%
Float 3.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.90
Forward PS n/a
PB Ratio 0.02
P/TBV Ratio 2.34
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.02.

Current Ratio 1.41
Quick Ratio 1.24
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.81

Financial Efficiency

Return on equity (ROE) is -123.28% and return on invested capital (ROIC) is -33.82%.

Return on Equity (ROE) -123.28%
Return on Assets (ROA) -25.23%
Return on Invested Capital (ROIC) -33.82%
Return on Capital Employed (ROCE) -57.65%
Weighted Average Cost of Capital (WACC) 28.52%
Revenue Per Employee $367,599
Profits Per Employee -$5.01M
Employee Count 2
Asset Turnover 0.04
Inventory Turnover 1.02

Taxes

In the past 12 months, Onconetix has paid $525 in taxes.

Income Tax 525
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.54% in the last 52 weeks. The beta is 2.72, so Onconetix's price volatility has been higher than the market average.

Beta (5Y) 2.72
52-Week Price Change -99.54%
50-Day Moving Average 3.21
200-Day Moving Average 72.96
Relative Strength Index (RSI) 27.20
Average Volume (20 Days) 715,371

Short Selling Information

The latest short interest is 51,883, so 1.41% of the outstanding shares have been sold short.

Short Interest 51,883
Short Previous Month 56,369
Short % of Shares Out 1.41%
Short % of Float 1.41%
Short Ratio (days to cover) 0.04

Income Statement

In the last 12 months, Onconetix had revenue of $735,198 and -$10.03 million in losses. Loss per share was -$300.31.

Revenue 735,198
Gross Profit 585,426
Operating Income -6.78M
Pretax Income -9.70M
Net Income -10.03M
EBITDA -6.77M
EBIT -6.78M
Loss Per Share -$300.31
Full Income Statement

Balance Sheet

The company has $3.72 million in cash and $289,922 in debt, giving a net cash position of $3.43 million or $0.93 per share.

Cash & Cash Equivalents 3.72M
Total Debt 289,922
Net Cash 3.43M
Net Cash Per Share $0.93
Equity (Book Value) 11.75M
Book Value Per Share 42.63
Working Capital 1.26M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.80M
Capital Expenditures n/a
Depreciation & Amortization 15,820
Net Borrowing -4.69M
Free Cash Flow -9.80M
FCF Per Share -$2.65
Full Cash Flow Statement

Margins

Gross Margin 79.63%
Operating Margin -922.72%
Pretax Margin -1,319.48%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -278.24%
FCF Yield -271.87%

Analyst Forecast

The average price target for Onconetix is $1,530,000.77, which is 156,682,006.50% higher than the current price. The consensus rating is "Hold".

Price Target $1,530,000.77
Price Target Difference 156,682,006.50%
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (3Y) 53.91%
EPS Growth Forecast (3Y) n/a

Stock Splits

The last stock split was on May 21, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date May 21, 2026
Split Type Reverse
Split Ratio 1:10

Scores

Onconetix has an Altman Z-Score of -13.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -13.56
Piotroski F-Score 4